Jonsson Comprehensive Cancer Center: Gliosarcoma trials

The registry lists 15 Gliosarcoma studies with Jonsson Comprehensive Cancer Center as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 1 9Phase 2 7No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG TrialRecruitingNCT07089641Phase 1
• Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01013285Phase 2Results posted
• Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT00998010Phase 2Results posted
• ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent GlioblastomaWithdrawnNCT04854044Phase 1
• Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent GlioblastomaWithdrawnNCT03014804Phase 2
• Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01149850Phase 2
• Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00612001Phase 1
• Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00509431Phase 1
• Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaCompletedNCT00087061Phase 1/2
• Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00068510Phase 1
• Sirolimus in Treating Patients With Glioblastoma MultiformeCompletedNCT00047073Phase 1/2
• Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain TumorsWithdrawnNCT00005083Phase 2
• Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaCompletedNCT00005082Not applicable
• Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade GliomasCompletedNCT00003410Phase 1
• Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00003409Phase 1